Sun Pharma Q1 Results : Cons profit falls 20% YoY to Rs 2,278 crore, but revenue rises (...)
Sun Pharma Q1 Results FY26: Sun Pharmaceutical Industries reported a 20% fall in Q1 consolidated net profit, reaching Rs 2,278 crore. Despite this dip, revenue from operations increased by 10% to Rs 13,786 crore. Strong performance in the India market and growth in global innovative medicines (...)
Site référencé: The Economic Times
The Economic Times
Days of US tech companies building factories in China, hiring workers in India 'over' : Trump
24/07/2025
ETMarkets Smart Talk| SIP inflows hit Rs 27,000 crore in June – Rising financial literacy and Gen Z participation driving growth : Ajay (...)
24/07/2025
US Treasury pullback from long-term bonds signals policy divergence, says Vishal Goenka
24/07/2025
Brigade Hotel Ventures’ Rs 760 crore IPO opens : Should you subscribe or skip ?
24/07/2025
Outward remittances down to $2.3 billion in May : RBI Bulletin
24/07/2025
RBI stepped in to prevent rupee's rise, net bought $1.7 billion
24/07/2025
